Luke Evnin, 10% owner at Entrada Therapeutics, sold TRDA on Aug 25, 2026
Data as of Oct 16
- Traded
- Aug 25, 2026
- Disclosed
- Aug 26, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
TRDA since disclosure
−37.6%
after the sale
Similar stocks (XLV) since disclosure
+1.8%
XLV — its sector index fund
Change in closing price from Aug 26, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
- ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
- ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
- ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
- ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
- ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
- ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
- ▼ SELLMPM BioVentures 2014 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
- ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
- ▼ SELLMPM BioVentures 2014, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
- ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$200Kdisclosed Aug 26 · filed 1 day after the trade
- ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$200Kdisclosed Aug 26 · filed 1 day after the trade
- ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$200Kdisclosed Aug 26 · filed 1 day after the trade
- ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$200Kdisclosed Aug 26 · filed 1 day after the trade
- ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$200Kdisclosed Aug 26 · filed 1 day after the trade